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Abstract: Atherosclerosis is considered as a  chronic, low-grade inflammatory process involving the 
aorta and the medium-sized arteries. Exposure to air pollutants, especially particulate matter, is highly 
related to cardiovascular diseases including atherosclerosis. Many studies confirm that proatherogenic 
potential of particulate matter is determined by its ability to induce inflammation, oxidative stress 
and thrombosis formation. Recently, an important role in the pathogenesis of atherosclerosis has been 
attributed to autoimmune response. Moreover, harmful effects of PM particles strongly depend on 
their physicochemical properties. It is still not known what exact role air pollutants, and in particular 
their inorganic part, play in the development of atherosclerotic lesions. In this article, we will briefly 
discuss the different aspects of particulate matter activity and its implication with atherosclerosis 
progression.
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Air pollution — core information
Chronic exposure to air pollutants is associated with numerous health prob lems  [1]. 
Air pollution is a  heterogeneous mixture consisting of various gaseous and solid 
substances. Among gaseous components we can distinguish: ozone (O3), carbon 
monoxide (CO), carbon dioxide (CO2), sulfur dioxide (SO2) and nitrogen oxides 
(NOx) [1]. Other components of air pollutants include: volatile organic compounds 
(benzopyrenes), coal dust, suspended dust and transition metals. A particularly 
unhealthy ingredient of air pollution is particulate matter emitted into the atmosphere 
as a result of anthropogenic processes, but also through natural phenomena. It widely 
recognized, that particulate matter has the greatest impact on human health of all 
air pollutants [2]. According to the World Health Organization (WHO) exposure to 
particulate matter can cause 3.7 million premature deaths worldwide per year [3]. 
Particulate matter (PM) may be defined as a  mixture of particles and liquid 
droplets suspended in the air, containing a  variety of organic and inorganic 
components. Examples of organic substances are polycyclic aromatic hydrocarbons 
(PAHs), furans and dioxins, while inorganic components include various ions and 
metals [3]. In this review we focused on the possible mechanisms linking biological 
actions of inorganic part of PM with atherogenesis. 
The degree of hazard of PM depends on their physicochemical properties such 
as chemical composition, size and solubility [4]. On the basis of the aerodynamic 
diameter, particulate matter can be divided into 3 main categories: PM10 called coarse 
thoracic particles, PM2.5 (fine particles) and PM0.1 (ultrafine particles) [1]. PM10 consists 
of particles 10 µm and smaller, which. could accumulate mainly in the upper parts 
of respiratory tract. Particles of PM2.5 (fine particles), which has a diameter less than 
2.5 µm can accumulate in the deep parts of the lungs. They deposit on the surface of 
the bronchioles and alveoli resulting in local pulmonary inflammation. Importantly, 
fine particles may also enter into the blood and cause systemic response. The PM2.5, 
may absorb on its surface bacteria, viruses and heavy metals such as lead, zinc, 
iron, cadmium, nickel, arsenic and chromium [5]. The American Heart Association 
point to PM2.5 as an important risk factor for cardiovascular events [4]. Numerous 
studies confirm the link between exposure to particulate matter and the progression 
of cardiovascular disease, including atherosclerosis, but the exact mechanisms 
responsible for harmful effects of the particulate matter are still unknown [6, 7]. 
Atherosclerosis — core mechanisms
Cardiovascular disorders, including atherosclerosis still represent the most common 
cause of death in Poland and the developed countries [8]. Atherosclerosis is a chronic 
disease of multifactorial etiology, however the widely accepted basis of the disease is 
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a  chronic, low-grade inflammatory process in progress in the arterial wall [9]. The 
first step in the development of atherosclerosis is endothelial dysfunction. Among the 
factors that may damage the endothelium are reactive oxygen and/or nitrogen species 
(ROS/RNS), oxidized biomolecules (like LDL), proinflammatory stimuli (cytokines, 
chemokines) or physical factors (high blood pressure, shear stress). Damaged 
endothelial cells start to show “inflammatory phenotype” which is characterized by 
an increased expression of adhesion molecules VCAM-1 and ICAM-1 and increased 
permeability of endothelium [10]. This results with the deposition of LDL in the 
subendothelial space, trapping of LDL by proteoglycans matrix and their oxidation 
into ox-LD. Recruited via adhesion molecules monocytes-macrophages absorb 
oxidized LDL and transform into foam cells [9]. The differentiation of monocytes into 
macrophages and foam cells depends on the action of endothelium-derived M-CSF 
(Macrophage colony-stimulating factor) and GM-CSF (Granulocyte-macrophage 
colony-stimulating factor) with subsequent expression of the scavenger receptors 
(SAR) and CD36 molecule, crucial for the interaction with lipoproteins [11, 12]. It 
has been shown that T lymphocytes early enter the atherosclerotic plaques [9]. They 
provide important source of inflammatory and pro-angiogenic factors (IL-8, IL-1, 
TNF-α and VEGF). The vicious cycle of atherogenesis develops: the overproduction 
of ROS derived by activated phagocytes, lymphocytes, endothelial cells and smooth 
muscle cells leads to the increased release of plethora of pro-inflammatory mediators 
(e.g. cytokines, chemokines, endothelins, angiotensins, prostaglandins), which 
in turn aggravate oxidative stress [13]. It has been shown that immune reactions 
represent important causative factor for atherosclerosis. Importantly, macrophages, 
endothelial cells and smooth muscle cells all express MHC II antigens, and they 
are able to present antigens to T lymphocytes. Both, T-helper 1 (Th1 — cellular) 
and T-helper  2 (Th2 — humoral) types of cells operate in plaques [14]. Th1 cells 
are considered as pro-atherogenic: they produce IFN-γ which is involved in the 
stimulation of the an expression of MHC class II molecules on antigen presenting 
cells (APC). It also stimulates the expression of VCAM-1 and ICAM-1, increases 
co-stimulatory signals (expression of CD40 and its ligand) and augment activity of 
metalloproteinases in phagocytes, endothelial and smooth muscle cells. The Th2 
cells, considered as anti-atherogenic produce the anti-inflammatory cytokines (IL-4, 
IL-5 and IL-10. IL-4 and IL-10) which inhibit the production of pro-inflammatory 
factors and metalloproteinases [14]. Regulatory T cells (Treg) produce transforming 
growth factor beta (TGF-β) and IL-10 cytokines that also determines their anti-
inflammatory and and antiatherogenic activities [15]. It seems, that the balance 
between Th1 and Th2 responses is tightly controlled by Treg [16]. Importantly, 
the platelets also take part in the atherogenesis as are a  source of growth factors 
such as PDGF (platelet-derived growth factor), responsible for the proliferation 
of smooth muscle cells and fibroblasts, and TGF-β which stimulates collagen 
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synthesis [17, 18]. In later stages of plaque development, chronic inflammation leads to 
an increased arterial calcification, which seems to be an active, organized and regulated 
process [19]. 
Mechanisms of atherogenic action of air pollutants
Oxidative stress and inflammation are considered the main culprits of endothelial 
dysfunction and development of atherosclerotic plaques. Thus, particulate matter 
can promote atherosclerosis, as a  consequence of its inflammatory and oxidative 
properties [20]. Particulate matter can generally act in two ways and both of these 
ways may contribute to atherosclerosis.
The first, indirect manner consists on initiation an inflammatory response in 
the lungs by PM2.5 and development of secondary systemic low-grade inflammation. 
Indeed, it has been shown that PM2.5 may directly cause oxidative injury of the 
respiratory epithelium, thereby leading to massive release of pro-inflammatory 
cytokines, that enter the circulation and trigger systemic inflammatory response [21].
The second mechanism assumes that PM2.5 passes from the respiratory tract into 
the circulation and cause direct damage and inflammatory stimulation of cells in 
vessel walls and blood (the mechanisms potentially involved in this way of action are 
described in details in next paragraphs).
Pro-oxidative activity of PM
Oxidative stress can be generally defined as an imbalance between the burden of 
reactive oxygen species (ROS) and the capacity of the cellular/tissue antioxidant 
systems. Importantly, ROS (esp. superoxide anion) may react with excess of nitric 
oxide  (NO) to form a  reactive nitrogen species (RNS) (esp. peroxynitrite) [4]. It is 
known, that severe oxidative stress may cause damage of macromolecules (proteins, 
lipids, nucleic acids) and cause cell apoptosis or necrosis. In vitro studies have 
demonstrated that PM2.5 may dose-dependently induce the apoptosis of human 
umbilical vein endothelial cells (HUVECs) via the p53, Bax and caspase 9, 7 and 
3 activation [22]. Such toxicity of PM is strongly associated with the capability of 
generating ROS/RNS and depends on chemical composition and the size of particles. 
Particulate matter contains transition metals, such as Fe, Pb, Cu, Cd and Mn, which 
participate in the formation of ROS and RNS. Transition metal ions can catalyze 
redox reactions and therefore generation of ROS on the surface of PM particles [23]. 
Ultrafine particles, due to their small size and relatively large surface, have a  larger 
oxidative potential than fine and coarse particles. Increased levels of ROS have 
been observed in various types of cells upon exposure to particulate matter, also 
in macrophages, endothelial and bronchial epithelial cells [24, 25]. Oxidative stress 
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has been shown to activate specific transcription factors, including nuclear factor-
kappa B (NF-κB) and activator protein-1 (AP-1), and pathways (e.g. Jun N-terminal 
kinase), which trigger the expression of genes for cytokines, chemokines, and 
other proinflammatory mediators [26]. Interestingly, the study on human aortic 
endothelial cells (HAEC), have shown that ambient ultrafine particles (UFP) also 
reduce physiological vascular nitric oxide (NO) production probably by stimulating 
S-glutathionylation of endothelial nitric oxide synthase (eNOS). Collectively, these 
observations indicate that exposure to ambient ultrafine pollutants can compromise 
the physiological, vascular action of NO by inhibition of its generation and/or by its 
scavenging by ROS with subsequent formation of toxic RNS [27]. It should be also 
noted that PM2.5-derived ROS/RNS may act also within blood. It has been shown 
that they may promote oxidation of low density lipoproteins (LDL) to ox-LDL (see 
below) [28].
Pro-inflammatory effects of PM
Inhalation of air pollutants can induce both local (pulmonary) and systemic 
inflammatory response. Several reports point to alveolar macrophages as to the 
key cells involved in local response to PM [29]. It has been shown, that they 
can recognize  PM2.5 via TLR2 or TLR4 Toll-like receptors (TLRs) and via NF-κB 
pathway activation release various pro-inflammatory mediators, such as IL-1, IL-6, 
TNF-a, GM-CSF and MCP-1 [24]. Pro-inflammatory cytokines and chemotactic 
proteins cause important local and systemic actions [4]. IL-6 may stimulate the 
bone marrow to produce white blood cells, platelets and acute phase proteins, what 
results in an increased white blood cell and platelet count in the blood. There are 
clear signs of systemic inflammatory response in people exposed to air pollution, e.g. 
there is positive correlation between exposure to particulate matter and the plasma 
concentration of C-reactive protein (CRP) [26]. In vitro studies clearly showed 
that PM2.5 and PM10 increase expression of the cell adhesion molecules: intercellular 
adhesion molecule-1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1) in 
human umbilical vein cells (HUVECs), as well as induce many other genes involved 
in inflammation [30]. Thus, systemic inflammatory response caused by particulate 
air pollution seems to play an important role in the development of cardiovascular 
diseases [29].
The impact of PM on plasma lipoproteins
Ambient particles were shown to alter lipid metabolism and properties of lipopro-
teins. They aggravate LDL oxidation as well as impair the function of scavenger 
receptors and LDL receptors and foster accumulation of lipids in atherosclerotic 
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plaques  [31]. Indeed, the studies on apolipoprotein E (apoE)-knockout mice model 
of atherosclerosis have shown increased content of cholesterol and macrophages in 
plaques after long-term exposure to low concentration of PM2.5 [32]. Particulate matter 
can also affect high density lipoprotein (HDL) by suppression of its anti-inflammatory 
and antioxidative capacity. It has been shown that the prolonged exposure of 
LDL-R null mice to ultrafine particles results in decrease of plasma HDL levels 
and their paraoxonase activity (PON), with simultaneous increase of triglycerides 
concentration [28]. The impairment of antioxidant and anti-inflammatory functions of 
HDL have been linked to an increase of oxidative stress and enhanced atherosclerosis 
progression [33].
The pro-thrombotic effect of PM
The exposure on particulate matter has been shown to increase thrombotic events [34]. 
PM may increase the concentrations of P-selectin and plasminogen activator 
inhibitor (PAI-1) in plasma while the levels of tissue factor pathway inhibitor  (TFPI) 
are reduced. Particles of PM can also increase activation of platelets and attenuate 
fibrinolysis, which may contribute to formation of arterial thrombus [35,  36]. It has 
been also demonstrated that long-term exposure to high concentrations of particulate 
matter results in changes in fibrin clot structure in patients with deep vein thrombosis. 
These patients have a  denser fibrin clot structures compared to patients exposed 
to low concentrations of PM [37]. Exposure to particulate matter may also lead to 
a hypercoagulability because of the increased levels of platelets and coagulation factors 
in the blood, such as fibrinogen, von Willebrand factor and factor VIII [34].
PM and atherosclerosis — a possible autoimmune connection
Several reports suggested, that immune reaction against autoantigen(s) might 
play significant role in the pathogenesis of atherosclerosis. Some studies pointed 
to the potential targets of immune response in atherosclerosis: the heat shock 
proteins (HSP), oxidized low density lipoproteins (ox-LDL), the β2 glycoprotein 
or the structural components of some microorganisms [38]. HSPs are expressed 
by the endothelial cells in response to shear stress and ox-LDLs and recognized by 
the  T  cells. It has been shown, that such scenario may play a  role in autoimmune 
reaction against the HSP60, which contribute to atherosclerosis [39, 40]. Intriguingly, 
in vitro studies showed that the exposure of endothelial cells to extract from cigarette 
smoke results in increased expression of HSP60 mRNA. HSP60 is localized in the 
mitochondria and it is responsible for their protection, however in response to 
cigarette smoke it is released from the mitochondria, transported to the endothelial 
cells surface and eventually shed to the circulation. Interestingly, elevated levels of 
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HSP60 in the serum have been reported in young healthy people exposed to passive 
smoking [39]. Few other mechanisms have been proposed to link atherogenesis, 
autoimmunity and air pollution. Pentraxin 3 (PTX3) plays an important role in the 
inflammatory and autoimmune diseases [41]. Recently, it was shown that inorganic 
part of PM in vitro induces release of long pentraxin 3 (PTX3) from THP-1 human 
leukemia monocytes and A549 human adenocarcinoma alveolar pneumocytes  [42]. 
There are also some clues pointing to the disturbances in function of suppressor 
regulatory T  cells  (Treg) upon exposure to common air pollutants [43]. Clearly, the 
involvement of autoimmune mechanisms in the pro-atherogenic action of particulate 
matter requires further extensive studies.
Summary
Many epidemiological studies and experimental data have shown that exposure 
to particulate matter is strongly associated with cardiovascular diseases. The pro-
atherogenic activity of particulate matter strongly depends on its physicochemical 
properties and could be attributed to its pro-oxidative, pro-inflammatory and 
pro-thrombotic potential. Several lines of evidence point to the important role 
of autoimmunity in pro-atherogenic action of particulate matters, however exact 
mechanistic links between atherogenesis and biological actions of inorganic part of 
particulate matter are still unclear and require further extensive studies.
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